These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25985938)

  • 21. P53 abnormalities and outcomes in colorectal cancer: a systematic review.
    Smith FM; Stephens RB; Kennedy MJ; Reynolds JV
    Br J Cancer; 2005 May; 92(9):1813. PubMed ID: 15856032
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
    Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
    Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA Damage Is a Potential Marker for TP53 Mutation in Colorectal Carcinogenesis.
    Scalise JR; Poças RC; Caneloi TP; Lopes CO; Kanno DT; Marques MG; Valdivia JC; Maximo FR; Pereira JA; Ribeiro ML; Priolli DG
    J Gastrointest Cancer; 2016 Dec; 47(4):409-416. PubMed ID: 27342962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.
    Sturm I; Köhne CH; Wolff G; Petrowsky H; Hillebrand T; Hauptmann S; Lorenz M; Dörken B; Daniel PT
    J Clin Oncol; 1999 May; 17(5):1364-74. PubMed ID: 10334520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
    Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting mutant p53 for cancer therapy.
    Oren M; Tal P; Rotter V
    Aging (Albany NY); 2016 Jun; 8(6):1159-60. PubMed ID: 27347904
    [No Abstract]   [Full Text] [Related]  

  • 28. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
    Ozakyol A; Ozdemir M; Artan S
    Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA.
    Gemignani F; Moreno V; Landi S; Moullan N; Chabrier A; Gutiérrez-Enríquez S; Hall J; Guino E; Peinado MA; Capella G; Canzian F
    Oncogene; 2004 Mar; 23(10):1954-6. PubMed ID: 14647431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
    Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
    J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers.
    Huang CC; Cheng YW; Chen MC; Lin YS; Chou MC; Lee H
    Environ Mol Mutagen; 2006 Aug; 47(7):527-32. PubMed ID: 16721749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
    Shimada S; Shiomori K; Tashima S; Tsuruta J; Ogawa M
    Br J Cancer; 2001 Jun; 84(11):1497-504. PubMed ID: 11384100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor suppressor genes in cancers of colon and rectum].
    Thomas G; Olschwang S; Laurent-Puig P
    Rev Prat; 1991 Nov; 41(23):2313-5. PubMed ID: 1792493
    [No Abstract]   [Full Text] [Related]  

  • 35. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
    Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of p53 gene abnormalities in carcinogenesis of human gastrointestinal tract].
    Tahara E; Yokozaki H
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):940-3. PubMed ID: 1470160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
    Wang XW; Harris CC
    Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
    Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
    Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability.
    Seth R; Keeley J; Abu-Ali G; Crook S; Jackson D; Ilyas M
    J Clin Pathol; 2009 Jul; 62(7):598-603. PubMed ID: 19261598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.